Announcing first positive Phase 3 topline results for our investigational individualized neoantigen therapy plus immunotherapy for certain patients with completely resected stage IIB-IV melanoma
Oncology
Our teams of researchers and scientists are pushing the boundaries of cancer research to discover more effective anticancer therapies.
Investors
Find our latest financials, events and presentations, news, stock information and investor contacts.
Sustainability
We operate responsibly every day to enable a safe and healthy future for people and communities globally.
Explore our stories
About us
For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines.
Pipeline
We follow the science where we can make the greatest difference, now and in the future.
Clinical trials
Clinical trials help find new treatments to help save and improve lives. Our progress is due in large part to the important and tough scientific questions we set out to answer with our trials and collaborations.
